Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags ...

23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s ...

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the company private. They are offering to buy all outstanding shares in cash for $2.53 per share, or an equity ...

23andMe's special committee of independent directors on Monday rejected CEO Anne Wojcicki's proposal to take the distressed ...

The genetic testing giant's CEO just made a desperate $2.94/share bid--after its stock cratered 99%. Will the board bite?

Me (ME) stock nosedived over 33% yesterday after the board unanimously rejected CEO Anne Wojcicki’s takeover offer. The company has set up ...

Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

23andMe ME1.34%increase; green up pointing triangle rejected its chief executive’s proposal to buy back the company at 41 cents a share as the struggling company explores strategic alternatives.

The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire the genetic testing company was rejected by a special committee of the Sunnyvale company's board, the group said Monday.

Ryan Sitton—the former Texas Railroad Commissioner and founder of engineering firm Pinnacle—has made an unsolicited offer to ...

A spe­cial com­mit­tee of 23andMe’s board re­ject­ed CEO Anne Wo­j­ci­c­ki’s lat­est of­fer to take the com­pa­ny pri­vate.

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...